Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan

Kengo Tokunaga 1Chihiro Suzuki 2Miyuki Hasegawa 2Ikuo Fujimori 21Department of General Medicine, Kyorin University School of Medicine, Tokyo, Japan; 2Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan   Correspondence: Kengo Tokunag...

Full description

Bibliographic Details
Main Authors: Tokunaga K, Suzuki C, Hasegawa M, Fujimori I
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
japanese claims database
cost analysis
potassium-competitive acid blocker
helicobacter pylori eradication
clarithromycin-dose
health resource
Online Access:https://www.dovepress.com/cost-analysis-in-helicobacter-pylori-eradication-therapy-based-on-a-da-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-analysis-in-helicobacter-pylori-eradication-therapy-based-on-a-da-peer-reviewed-article-CEOR

Similar Items